Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Absci Corporation (ABSI) Cash Flow Statement

Absci Corporation (ABSI) generated -$108.1M of operating cash flow over the twelve months to 2026-06-30, spent $890000 on capital expenditure and had free cash flow of -$109.0M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABSIAbsci CorporationFollow ABSI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.6B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-60.6-81.3-64.6-72.4-92.9-108.1
Capital expenditure38.016.20.90.41.1-0.9
Free cash flow-98.6-97.5-65.5-72.8-94.0-109.0
Stock-based compensation10.612.511.419.518.3—

USD millions · SEC XBRL

Absci Corporation — questions

What is Absci Corporation's operating cash flow?
-$108.1M over the twelve months to 2026-06-30.
How much does Absci Corporation spend on capital expenditure?
$890000 over the twelve months to 2026-06-30.
What is Absci Corporation's free cash flow?
-$109.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Absci Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.